This announcement is a separate document:
南新制药:关于重大资产重组进展暨变更独立财务顾问的公告
Nanxin Pharmaceutical: Announcement on the progress of major asset restructuring and the change of independent financial adviser
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.